Results of Operations and Financial Condition. On August 5, 2026, Novanta Inc. (the “Company”) issued a press release announcing its financial results for the fiscal quarter ended July 3, 2026. A copy of this press release is attached hereto as Exhibit 99.1. The information contained in this Current Report, including Exhibit 99.1, is furnished under this

of the Previous Form 8-K is incorporated into this

Completion of Acquisition or Disposition of Assets As previously disclosed in the Current Report on Form 8-K filed on June 8, 2026 (the “ Previous Form 8-K ”), by Novanta Inc., a Canadian corporation (the “ Company ”) with the Securities and Exchange Commission, on June 8, 2026, the Company, Novanta Medical Technologies Corp., a Delaware corporation and an indirect subsidiary of the Company (“ Buyer ”), Novanta Corporation, a Michigan corporation (“ Intermediate Parent ”, and together with th…

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. On July 22, 2026, to fund the Transaction, Intermediate Parent borrowed $616.0 million in the aggregate under its revolving credit facility and delayed draw term loan facility under its Fourth Amended and Restated Credit Agreement (the “ Credit Agreement ”) and funded the remaining consideration with cash on hand. Borrowings under the revolving credit facility and delayed draw te…

Unregistered Sales of Equity Securities The information contained in Item 1.01 01 of this Current Report on Form 8-K is incorporated by reference into this

Other Events. On June 9, 2026, the Company issued a press release announcing the pricing of the Private Placement described in

Regulation FD Disclosure. On June 9, 2026, the Company issued a press release announcing the Transaction. A copy of the press release is furnished with this Form 8-K and attached hereto as Exhibit 99.1. Also on June 9, 2026, the Company will hold a conference call to discuss the Transaction. A copy of the conference call presentation is attached hereto as Exhibit 99.2 and is also available on the Company’s website, https://www.novanta.com, in the Investor section. Exhibits 99.1 and 99.2 shall…

Entry into a Material Definitive Agreement. On June 8, 2026, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) for a private placement (the “Private Placement”) with certain institutional and other accredited investors (each, a “Purchaser” and collectively, the “Purchasers”). The closing of the Private Placement (the “Closing”) is expected to occur on June 11, 2026, subject to the satisfaction of customary closing conditions. Pursuant to the Purchase Agreemen…

Entry into a Material Definitive Agreement. Equity Purchase Agreement On June 8, 2026, Novanta Inc., a Canadian corporation (the “ Company ”), Novanta Medical Technologies Corp., a Delaware corporation and an indirect subsidiary of the Company (“ Buyer ”), Novanta Corporation, a Michigan corporation (“ Intermediate Parent ”, and together with the Company and the Buyer, the “ Buyer Parties ”), Runway Midco, LLC, a Delaware limited liability company (“ Seller ”), and Runway Buyer, LLC, a Delawa…

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information set forth in

Entry into a Material Definitive Agreement. On May 15, 2026 (the “Second Amendment Effective Date”), Novanta Inc. (the “Company”), Novanta Corporation (the “Lead Borrower”), Novanta UK Investments Holding Limited (the “U.K. Borrower”), Novanta Europe GmbH (the “German Borrower” and, together with the Company, the Lead Borrower and the U.K. Borrower, the “Borrowers”) and certain wholly-owned subsidiaries of the Company (the “Guarantors”) entered into the Second Amendment to Fourth Amended and…

Results of Operations and Financial Condition. On May 11, 2026, Novanta Inc. (the “Company”) issued a press release announcing its financial results for the fiscal quarter ended April 3, 2026. A copy of this press release is attached hereto as Exhibit 99.1. The information contained in this Current Report, including Exhibit 99.1, is furnished under this

Results of Operations and Financial Condition. On February 23, 2026, Novanta Inc. (the “Company”) issued a press release announcing its financial results for the fiscal quarter and full year December 31, 2025. A copy of this press release is attached hereto as Exhibit 99.1. The information contained in this Current Report, including Exhibit 99.1, is furnished under this

Regulation FD Disclosure. Novanta Inc. (“Novanta” or the “Company”) revised certain fourth quarter and full year 2025 financial guidance to reflect the completion of the recent equity issuance. The updated non-GAAP adjusted diluted earnings per share (“Adjusted Diluted EPS”) guidance for the fourth quarter and full year 2025 is $0.84 to $0.91 and $3.21 to $3.28, respectively. The prior Adjusted Diluted EPS guidance for the fourth quarter and full year 2025 was $0.87 to $0.93 and $3.24 to $3.3…

Entry into a Material Definitive Agreements. Underwriting Agreement On November 6, 2025, the Company entered into an underwriting agreement (the “ Underwriting Agreement ”), among the Company and J.P. Morgan Securities LLC and BofA Securities, Inc., as representatives (the “ Representatives ”) of the several underwriters (the “ Underwriters ”), pursuant to which the Company agreed to sell 11,000,000 of its 6.50% tangible equity units (“ Units ”) at a public offering price of $50.00 per Unit (…

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information set forth under

Results of Operations and Financial Condition. On November 3, 2025, Novanta Inc. (the “Company”) issued a press release announcing its financial results for the fiscal quarter ended September 26, 2025. A copy of this press release is attached hereto as Exhibit 99.1. The information contained in this Current Report, including Exhibit 99.1, is furnished under this

Director — Barbara Hulit: A director resigned from the board and committees without any stated disagreement, representing a standard board turnover event rather than a senior executive departure.

Other Matters. On September 18, 2025, the Novanta Inc. (the "Company") issued a press release announcing that its Board of Directors (the "Board") authorized the repurchase of up to an additional $200.0 million of the Company’s outstanding common shares. As of September 18, 2025, $31.0 million remained available for repurchase under the Company's 2020 Board share repurchase authorization, for a total available capacity of $231.0 million. Shares may be purchased on a discretionary basis from t…

Results of Operations and Financial Condition. On August 5, 2025, Novanta Inc. (the “Company”) issued a press release announcing its financial results for the fiscal quarter ended June 27, 2025. A copy of this press release is attached hereto as Exhibit 99.1. The information contained in this Current Report, including Exhibit 99.1, is furnished under this

General Counsel — Michele D. Welsh: The General Counsel is departing with standard severance terms, representing a genuine loss of a senior officer but without the shock of a sudden CEO/CFO exit or termination for cause.

Entry into a Material Definitive Agreement. On June 27, 2025, Novanta Inc. (the “Company”), Novanta Corporation (the “Lead Borrower”) Novanta UK Investments Holding Limited (the “U.K. Borrower”), Novanta Europe GmbH (the “German Borrower” and, together with the Company, the Lead Borrower and the U.K. Borrower, the “Borrowers”) entered into the Fourth Amended and Restated Credit Agreement (the “Agreement”) with Bank of America, N.A., as Administrative Agent, Swing Line Lender, L/C Issuer and l…

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information set forth in

Costs Associated with Exit or Disposal Activities On June 3, 2025, Novanta Inc. (the “Company”) committed to a restructuring plan (the “2025 Restructuring Plan”) to streamline operations and align with long-term goals. The 2025 Restructuring Plan includes measures to regionalize manufacturing operations, expedite the closure of certain sites, streamline management structures, and implement cost-saving strategies in areas anticipated to have a minimal long-term impact on the Company's overall…

Results of Operations and Financial Condition. On May 6, 2025, Novanta Inc. (the “Company”) issued a press release announcing its financial results for the fiscal quarter ended March 28, 2025. A copy of this press release is attached hereto as Exhibit 99.1. The information contained in this Current Report, including Exhibit 99.1, is furnished under this